PharmaLab Japan

March 10, 2026  Source: drugdu 30

"/

Organiser:Reed Exhibitions

Time:May 20 - 22, 2026

Address:3-21-1 Ariake, Koto-ku, Tokyo 135-0063, Japan

Exhibition hall:Tokyo Big Sight International Exhibition Center

 

Product range:

General Exhibition Area: Products related to cell biology, drug research, various equipment, consumables, reagents, products related to biological omics, biological imaging equipment, software, databases, biological resources, biological materials, biological industry clusters, investment, industrial upgrading, etc.

Regenerative Medicine Research Exhibition Area: Cell culture, cell production products/services, regenerative medicine, cellular medicine, etc.

Contract Services Exhibition Area: Contract research and development, testing, analysis, contract expression, synthesis, refinement, clinical research CMO, CRO, SMO, technology transfer TLO, IP consulting, etc.

Precision Processing Exhibition Area: Precision/fine processing technologies, microfluidics (microTAS, Bio MEMS, biochips, biosensors), microchannels, microsystems, etc.

 

About PharmaLab Japan:

PharmaLab Japan is one of Asia's leading pharmaceutical laboratory exhibitions. The highly anticipated 250 conference/seminar events will provide attendees with the best venue to learn about life sciences knowledge. As a comprehensive biotechnology exhibition, it is widely recognized in the industry and brings together professionals, products, technologies, and information from the global biotechnology sector. The previous edition of PharmaLab Japan covered a total area of 28,000 square meters, with 517 exhibiting companies from countries and regions such as China, South Korea, Russia, Dubai, India, Brazil, and Germany, attracting 43,000 attendees. The exhibition covers the entire biopharmaceutical industry, including drug development, genomics, proteomics, cell research, and regenerative medicine.

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.